Patrick Yang

Patrick Yuhmin Yang is the founder of Acepodia Biotechnologies, Ltd., founded in 2017.
Dr. Yang is the founder of Acepodia, Inc., founded in 2017, and holds the titles of Chairman, Chief Strategy Officer & Deputy GM since 2023.
Dr. Yang is the founder of National Resilience, Inc., founded in 2020, and holds the title of Vice Chairman since 2020.
Current jobs include Chairman at AbGenomics International, Inc. and AltruBio, Inc.; Director at Antheia, Inc., Polaris Group, Tetra Tech Tesoro, Inc., Taiwania Capital Management USA, Inc., Archigen Biotech Ltd., and Aspen Sciences LLC; Independent Director at PharmaEssentia Corp.
since 2014 and Sana Biotechnology, Inc. since 2018.
Former jobs include Independent Director at Andeavor LLC (2011–2018), Codexis, Inc. (2014–2023), Celladon Corp.
(2014–2015), and Amyris, Inc. (2014–2021); Director at Polaris Pharmaceuticals, Inc.; Director at TaiMed, Inc. (2007–2009); Executive Vice President-Product Operations at Genentech, Inc. (2003–2009); Principal at GE Aerospace (1980–1992); VP-Asia & Pacific Manufacturing Operations at Merck & Co., Inc. (1992–2003); EVP & Head-Pharmaceutical Technical Operations at F.
Hoffmann-La Roche Ltd. (2010–2013); Principal at Life Systems, Inc.; Executive Vice President at Juno Therapeutics, Inc. (2017–2019).
Education includes a doctorate from The Ohio State University, graduate studies at the University of Cincinnati (Ohio), and undergraduate studies at National Chiao Tung University.